However, tumour volume correlated to the percentage of GFAP+CD16+ monocytes for both GBM (r = 0.215; P = 0.010) and brain metastasis (r = 0.504; P = 0.010) (Supplementary Fig. 6C). The gene discussed is GFAP; the disease is glioblastoma.